Free Republic 4th Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $57,228
70%  
Woo hoo!! And we're now over 70%!! Thank you all very much!! God bless.

Keyword: livercancertreatment

Brevity: Headers | « Text »
  • Combined therapy makes headway for liver cancer

    05/06/2024 1:09:43 PM PDT · by ConservativeMind · 3 replies
    A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a clinical trial. The findings show the potential benefits of augmenting immunotherapy for this and other forms of cancer. Several years ago, researchers discovered that phosphatidylserine, a fatty substance called a phospholipid sometimes present on the surface of cancer cells, appeared to interact with immune cells to prevent them from attacking tumors. An antibody drug called bavituximab that neutralizes phosphatidylserine showed no effect on tumor response, progression, or survival when administered alone...